14-49634964-C-T
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_018139.3(DNAAF2):c.186G>A(p.Glu62Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_018139.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 10Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018139.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes Cov.: 36
GnomAD2 exomes AF: 0.0000366 AC: 6AN: 163802 AF XY: 0.0000225 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000497 AC: 7AN: 1408246Hom.: 0 Cov.: 111 AF XY: 0.00000431 AC XY: 3AN XY: 695788 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 36
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at